M2 Pharma - Therapy Areas

Cancer Prevention Pharmaceuticals Submits New Drug Application to the FDA for CPP-1X/sul for Treatment of Familial Adenomatous Polyposis

2 July 2020 - - US-based biotechnology company Cancer Prevention Pharmaceuticals, Inc has submitted a New Drug Application to the US Food and Drug Administration seeking accelerated approval for CPP-1...

Goldfinch Bio Secures USD 100m in Series B Financing

2 July 2020 - - US-based biotechnology company Goldfinch Bio has closed an oversubscribed series B financing, which raised USD 100m, the company said.

The financing was led by Eventide A...

Novo Nordisk reports approval of Rybelsus in Japan for the treatment of type 2 diabetes

30 June 2020 - Global pharmaceutical and healthcare company Novo Nordisk A/S (CPH:NOVOB) announced on Monday the approval by the Japanese Ministry of Health, Labour and Welfare of Rybelsus (oral semag...

New COVID-19 Projections Warn of Accelerating Epidemic in Arizona, Texas and Florida

24 June 2020 - - Updated county-level COVID-19 projections released on Wednesday by PolicyLab at Children's Hospital of Philadelphia (CHOP) forecast a deteriorating situation ...

COVID-19 Pandemic Dramatically Increased Out-of-Hospital Cardiac Arrest Cases and Deaths in New York City

19 June 2020 - - The COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests and deaths, according to a study co-authored by researchers at Albert Einstein Colle...

Oramed Pharmaceuticals reveals pilot study results for ORMD-0801 in type two diabetes patients with NASH

16 June 2020 - Oramed Pharmaceuticals Inc (Nasdaq: ORMP) (TASE: ORMP), an Israeli clinical-stage pharmaceutical company, has revealed that the pilot study of its oral insulin candidate ORMD-0801 in ty...